CollPlant Biotechnologies Ltd

CLGN

Exchange: Nasdaq
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK: 0001631487

SEC filings (opens in a new tab)

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding CollPlant Biotechnologies Ltd changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of CLGN: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	18	18	0
Shares	1.58M	1.55M	−28.3K (−1.8%)
Value	$13.1M	$10.9M	−$2.20M (−16.9%)

New holders (2)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CLGN in Q1 2023
Institution	Shares	Value	% of portfolio
Shay Capital LLC	10,000	$70.2K	0.03%
Focused Wealth Management, Inc	242	$1.70K	0.00%

Sold out (2)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of CLGN in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Credit Suisse AG	6,100	$50.9K
Private Advisor Group, LLC	10,490	$88